This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Centers for Medicare & Medicaid Services (CMS) has announced a 2.83% reduction in the Medicare Physician Fee Schedule (PFS) for 2025. Key Points of the 2025 PFS Reduction The 2025 PFS introduces a reduced conversion factor of $32.35, down from $33.29
Better MedicationManagement According to the National Institutes of Health (NIH ), improper medicationmanagement contributes to up to 50% of hospital readmissions among chronic disease patients. PharmD Lives MedicationTherapyManagement (MTM) services are critical in combating this issue.
WASHINGTON, February 18, 2025 PharmD Live , an innovative pharmacist-led virtual care solution powered by AI-driven algorithms, announces the release of its recent white paper, Maximizing Shared Savings for Payviders: ACOs, IDNs, At-Risk Provider Groups and Clinics.
Part D MedicationTherapyManagement (MTM) Program Eligibility Criteria Ensuring access to Part D medication is crucial in closing coverage gaps. CMS is proposing dementia and Alzheimer’s disease to be a part of the Part D MedicationTherapyManagement (MTM) program.
Part D MedicationTherapyManagement (MTM) Program Eligibility Criteria The NHC welcomes CMS proposal to expand eligibility criteria for the Medicare Part D MTM program to include beneficiaries with other forms of dementia in addition to Alzheimers disease. Accessed January 2, 2025. 42 Maria T.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content